Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

5-fluorouracil

  • You have access
    Expression of ATP-binding Cassette Transporter 11 (ABCC11) Protein in Colon Cancer
    YASUFUMI YAMADA, KAZUHIKO YOSHIMATSU, HAJIME YOKOMIZO, SACHIYO OKAYAMA and SHUNICHI SHIOZAWA
    Anticancer Research October 2020, 40 (10) 5405-5409; DOI: https://doi.org/10.21873/anticanres.14549
  • You have access
    Casein Kinase 2α Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress
    HYUNG JOO KIM, YONG-SEOK HAN, JUN HEE LEE and SANG HUN LEE
    Anticancer Research March 2020, 40 (3) 1419-1426; DOI: https://doi.org/10.21873/anticanres.14083
  • You have access
    VDR Agonists Increase Sensitivity of MCF-7 and BT-474 Breast Cancer Cells to 5 FU
    DAGMARA KLOPOTOWSKA and JANUSZ MATUSZYK
    Anticancer Research February 2020, 40 (2) 837-840; DOI: https://doi.org/10.21873/anticanres.14015
  • You have access
    Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model
    GUANGWEI ZHU, MING ZHAO, QINGHONG HAN, YUYING TAN, YU SUN, MICHAEL BOUVET, BRYAN CLARY, SHREE RAM SINGH, JIANXIN YE and ROBERT M. HOFFMAN
    Anticancer Research December 2019, 39 (12) 6463-6470; DOI: https://doi.org/10.21873/anticanres.13860
  • You have access
    Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model
    GUANGWEI ZHU, MING ZHAO, QINGHONG HAN, YUYING TAN, YU SUN, MICHAEL BOUVET, SHREE RAM SINGH, JIANXIN YE and ROBERT M. HOFFMAN
    Anticancer Research November 2019, 39 (11) 5999-6005; DOI: https://doi.org/10.21873/anticanres.13805
  • You have access
    Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model
    HIROMICHI OSHIRO, YASUNORI TOME, TASUKU KIYUNA, SANG NAM YOON, THINZAR M. LWIN, QINGHONG HAN, YUYING TAN, KENTARO MIYAKE, TAKASHI HIGUCHI, NORIHIKO SUGISAWA, YUKI KATSUYA, JUN HO PARK, ZHIYING ZANG, SAHAR RAZMJOOEI, MICHAEL BOUVET, BRYAN CLARY, SHREE RAM SINGH, FUMINORI KANAYA, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Anticancer Research September 2019, 39 (9) 4667-4671; DOI: https://doi.org/10.21873/anticanres.13648
  • You have access
    5-Aza-2-deoxycytidine Enhances the Sensitivity of 5-Fluorouracil by Demethylation of the Thymidine Phosphorylase Promoter
    YUKIHIKO NISHIZAWA, RYUJI IKEDA, MASATATSU YAMAMOTO, KOHICHI KAWAHARA, YOSHINARI SHINSATO, KENTARO MINAMI, MINA NITTA, HIDEYUKI TERAZONO, SHIN-ICHI AKIYAMA, TATSUHIKO FURUKAWA and YASUO TAKEDA
    Anticancer Research August 2019, 39 (8) 4129-4136; DOI: https://doi.org/10.21873/anticanres.13571
  • You have access
    A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
    MATTHEW R. KEARNEY, EMERSON Y. CHEN, GINA M. VACCARO, JOHN STROTHER, ANDREA BURT, KENDRA TODD, JEFF DONOVAN, KERSTIN M. KAMPA-SCHITTENHELM and CHARLES D. LOPEZ
    Anticancer Research January 2019, 39 (1) 245-252; DOI: https://doi.org/10.21873/anticanres.13104
  • You have access
    Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression
    SAWAKO MIYOSHI, HITOSHI TSUGAWA, JUNTARO MATSUZAKI, KENRO HIRATA, HIDEKI MORI, HIDEYUKI SAYA, TAKANORI KANAI and HIDEKAZU SUZUKI
    Anticancer Research November 2018, 38 (11) 6163-6170; DOI: https://doi.org/10.21873/anticanres.12969
  • You have access
    Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer
    YUKI SUEHIRO, YOSHIHIRO TAKEMOTO, ARATA NISHIMOTO, KOJI UENO, BUNGO SHIRASAWA, TOSHIKI TANAKA, NARUJI KUGIMIYA, ATSUSHI SUGA, EIJIRO HARADA and KIMIKAZU HAMANO
    Anticancer Research November 2018, 38 (11) 6225-6230; DOI: https://doi.org/10.21873/anticanres.12977

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire